US4479795A
(en)
*
|
1979-06-29 |
1984-10-30 |
The Procter & Gamble Company |
Antimicrobial polymer compositions
|
US4764380A
(en)
*
|
1982-03-22 |
1988-08-16 |
Alza Corporation |
Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
|
US5366738A
(en)
*
|
1982-07-29 |
1994-11-22 |
Merck & Co., Inc. |
Controlled release drug dispersion delivery device
|
US4466705A
(en)
*
|
1982-09-30 |
1984-08-21 |
Michelson Paul E |
Fluid lens
|
US4709996A
(en)
*
|
1982-09-30 |
1987-12-01 |
Michelson Paul E |
Fluid lens
|
US4613330A
(en)
*
|
1982-11-26 |
1986-09-23 |
Michelson Paul E |
Delivery system for desired agents
|
GB8305797D0
(en)
*
|
1983-03-02 |
1983-04-07 |
Graham N B |
Hydrogel-containing envelopes
|
AT394944B
(de)
*
|
1983-05-11 |
1992-07-27 |
Alza Corp |
Verfahren zur herstellung einer vorrichtung zur abgabe eines wirkstoffes, insbesondere eines heilmittels, an eine waesserige verwendungsumgebung
|
US4783337A
(en)
*
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
NZ206600A
(en)
*
|
1983-05-11 |
1987-01-23 |
Alza Corp |
Osmotic drug delivery device
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
US4765989A
(en)
*
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
USRE33994E
(en)
*
|
1983-08-16 |
1992-07-14 |
Burroughs Wellcome Co. |
Pharmaceutical delivery system
|
AU591171B2
(en)
*
|
1983-11-02 |
1989-11-30 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US4781714A
(en)
*
|
1983-11-02 |
1988-11-01 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US4627850A
(en)
*
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US5000957A
(en)
*
|
1984-03-19 |
1991-03-19 |
Alza Corporation |
Dispenser comprising hydrophilic osmopolymer
|
US4595583A
(en)
*
|
1984-03-19 |
1986-06-17 |
Alza Corporation |
Delivery system controlled administration of beneficial agent to ruminants
|
US4844984A
(en)
*
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4772474A
(en)
*
|
1985-08-09 |
1988-09-20 |
Alza Corporation |
Dispenser with internal arrangement of lamina means for dispensing beneficial agent
|
US4717566A
(en)
*
|
1984-03-19 |
1988-01-05 |
Alza Corporation |
Dosage system and method of using same
|
US4927633A
(en)
*
|
1984-03-19 |
1990-05-22 |
Alza Corporation |
Dispenser for delivering drug to livestock
|
US4624945A
(en)
*
|
1984-03-19 |
1986-11-25 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4729793A
(en)
*
|
1985-08-09 |
1988-03-08 |
Alza Corporation |
Composition for manufacturing wall of dispensing device
|
US4663149A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising inner and outer walls functioning as cooperative unit
|
US4814180A
(en)
*
|
1984-03-21 |
1989-03-21 |
Alza Corporation |
Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
|
GB2155889B
(en)
*
|
1984-03-21 |
1988-03-02 |
Alza Corp |
Dispenser-capsule
|
US4716031A
(en)
*
|
1984-03-21 |
1987-12-29 |
Alza Corporation |
Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
|
US4692326A
(en)
*
|
1984-03-21 |
1987-09-08 |
Alza Corporation |
Dispenser comprising inner positioned soft or hard capsule
|
US4663148A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising telescopically engaging members
|
US4678467A
(en)
*
|
1984-03-21 |
1987-07-07 |
Alza Corporation |
Dispenser comprising capsule with volume displacing member
|
US4627971A
(en)
*
|
1985-04-22 |
1986-12-09 |
Alza Corporation |
Osmotic device with self-sealing passageway
|
US4609374A
(en)
*
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4624847A
(en)
*
|
1985-04-22 |
1986-11-25 |
Alza Corporation |
Drug delivery device for programmed delivery of beneficial drug
|
US4717568A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Laminar arrangement for increasing delivery of beneficial agent from dispenser
|
US4717718A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Device for the controlled delivery of a beneficial agent
|
US4966767A
(en)
*
|
1985-08-16 |
1990-10-30 |
Alza Corporation |
Ruminant dispensing device comprising agent displacement member
|
US5098425A
(en)
*
|
1985-08-16 |
1992-03-24 |
Alza Corporation |
Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member
|
US4955881A
(en)
*
|
1985-08-16 |
1990-09-11 |
Alza Corporation |
Ruminant dispensing device
|
US4865598A
(en)
*
|
1985-08-16 |
1989-09-12 |
Alza Corporation |
Dispensing system for administering beneficial agent
|
US4704118A
(en)
*
|
1985-08-16 |
1987-11-03 |
Alza Corporation |
Ruminant dispensing device with thermo-activated memory
|
US4883667A
(en)
*
|
1985-08-16 |
1989-11-28 |
Alza Corporation |
Process for forming dispensing device
|
US4963141A
(en)
*
|
1985-08-16 |
1990-10-16 |
Alza Corporation |
Dispensing system for administering beneficial agent formulation to ruminants
|
US4871544A
(en)
*
|
1985-08-16 |
1989-10-03 |
Alza Corporation |
Ruminant dispensing device
|
US4643731A
(en)
*
|
1985-08-16 |
1987-02-17 |
Alza Corporation |
Means for providing instant agent from agent dispensing system
|
US4866040A
(en)
*
|
1986-01-06 |
1989-09-12 |
Alfred Stracher |
Aminocarnitine directed pharmaceutical agents
|
US5008288A
(en)
*
|
1986-01-06 |
1991-04-16 |
Alfred Stracher |
Carnitine directed pharmaceutical agents
|
US4747847A
(en)
*
|
1986-02-07 |
1988-05-31 |
Alza Corporation |
System for delivering potassium chloride with enhanced bioacceptability
|
US4971790A
(en)
*
|
1986-02-07 |
1990-11-20 |
Alza Corporation |
Dosage form for lessening irritation of mocusa
|
US4867969A
(en)
*
|
1986-02-07 |
1989-09-19 |
Alza Corporation |
Hydrogel formulation for administering non-steroidal drugs
|
US4723957A
(en)
*
|
1986-02-07 |
1988-02-09 |
Alza Corp. |
System for delivering drug with enhanced bioacceptability
|
US4865845A
(en)
*
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
GB2189702B
(en)
*
|
1986-04-30 |
1989-10-18 |
Alza Corp |
Dosage form with improved delivery capability
|
US4960416A
(en)
*
|
1986-04-30 |
1990-10-02 |
Alza Corporation |
Dosage form with improved delivery capability
|
US4863456A
(en)
*
|
1986-04-30 |
1989-09-05 |
Alza Corporation |
Dosage form with improved delivery capability
|
US4723958A
(en)
*
|
1986-05-23 |
1988-02-09 |
Merck & Co., Inc. |
Pulsatile drug delivery system
|
US4755180A
(en)
*
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
US4983400A
(en)
*
|
1986-06-16 |
1991-01-08 |
Merck & Co., Inc. |
Controlled release combination of carbidopa/levodopa
|
USRE34990E
(en)
*
|
1986-08-07 |
1995-07-04 |
Ciba-Geigy Corporation |
Oral therapeutic system having systemic action
|
CH668187A5
(de)
*
|
1986-08-07 |
1988-12-15 |
Ciba Geigy Ag |
Therapeutisches system mit systemischer wirkung.
|
ATE72111T1
(de)
*
|
1987-01-14 |
1992-02-15 |
Ciba Geigy Ag |
Therapeutisches system fuer schwerloesliche wirkstoffe.
|
JPS63180224A
(ja)
*
|
1987-01-21 |
1988-07-25 |
Matsushita Electric Ind Co Ltd |
無線機のアンテナ回路
|
US4892778A
(en)
*
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
US4940465A
(en)
*
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US4876093A
(en)
*
|
1987-07-02 |
1989-10-24 |
Alza Corporation |
Dispenser with dispersing member for delivering beneficial agent
|
US4915949A
(en)
*
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4824675A
(en)
*
|
1987-07-13 |
1989-04-25 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4891223A
(en)
*
|
1987-09-03 |
1990-01-02 |
Air Products And Chemicals, Inc. |
Controlled release delivery coating formulation for bioactive substances
|
US4950486A
(en)
*
|
1987-10-02 |
1990-08-21 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4946687A
(en)
*
|
1987-10-02 |
1990-08-07 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4816263A
(en)
*
|
1987-10-02 |
1989-03-28 |
Alza Corporation |
Dosage form for treating cardiovascular diseases comprising isradipine
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5030456A
(en)
*
|
1988-11-07 |
1991-07-09 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US5376383A
(en)
*
|
1988-11-21 |
1994-12-27 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma-cholesterol levels
|
US4997658A
(en)
*
|
1988-11-21 |
1991-03-05 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma cholesterol levels
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
IL92966A
(en)
*
|
1989-01-12 |
1995-07-31 |
Pfizer |
Hydrogel-operated release devices
|
US5030452A
(en)
*
|
1989-01-12 |
1991-07-09 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
DD295760A5
(de)
*
|
1989-01-31 |
1991-11-14 |
Martin-Luther-Universitaet Halle Wittenberg,De |
Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
|
IE69174B1
(en)
*
|
1989-01-31 |
1996-08-07 |
Int Pharma Agentur |
A system for the controlled release of active agents and a process for its preparation
|
US6200600B1
(en)
*
|
1989-02-16 |
2001-03-13 |
Btg International Limited |
Controlled delay release device
|
US5181505A
(en)
*
|
1989-03-08 |
1993-01-26 |
Lew Chel W |
Method and apparatus for delivery of a medicament in the oral cavity
|
US5002540A
(en)
*
|
1989-05-22 |
1991-03-26 |
Warren Kirschbaum |
Intravaginal device and method for delivering a medicament
|
US5021053A
(en)
*
|
1989-07-14 |
1991-06-04 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5776493A
(en)
*
|
1989-07-14 |
1998-07-07 |
Alza Corporation |
Oral osmotic device for delivery of nystatin with hydrogel driving member
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5120548A
(en)
*
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5098714A
(en)
*
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
US5030216A
(en)
*
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
US5660851A
(en)
*
|
1989-12-26 |
1997-08-26 |
Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem |
Ocular inserts
|
US5223266A
(en)
*
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5128145A
(en)
*
|
1990-06-13 |
1992-07-07 |
Alza Corporation |
Dosage form for Parkinson's disease, spasticity and muscle spasms
|
US5057321A
(en)
*
|
1990-06-13 |
1991-10-15 |
Alza Corporation |
Dosage form comprising drug and maltodextrin
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
NZ238867A
(en)
*
|
1990-07-12 |
1993-08-26 |
Alza Corp |
Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
|
US5147654A
(en)
*
|
1990-07-23 |
1992-09-15 |
Alza Corporation |
Oral osmotic device for delivering nicotine
|
US5431921A
(en)
*
|
1990-09-28 |
1995-07-11 |
Pfizer Inc |
Dispensing device containing a hydrophobic medium
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US5593852A
(en)
|
1993-12-02 |
1997-01-14 |
Heller; Adam |
Subcutaneous glucose electrode
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5208037A
(en)
*
|
1991-04-22 |
1993-05-04 |
Alza Corporation |
Dosage forms comprising polymers comprising different molecular weights
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5190765A
(en)
*
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
US5252338A
(en)
*
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
US5178867A
(en)
*
|
1991-08-19 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug in short-time period
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
JPH07500264A
(ja)
*
|
1991-10-10 |
1995-01-12 |
アルザ・コーポレーション |
疎水性壁材料による浸透圧薬物投与デバイス
|
US5266332A
(en)
*
|
1991-12-06 |
1993-11-30 |
Alza Corporation |
Method for administering anti-Parkinson drug
|
US5254349A
(en)
*
|
1991-12-06 |
1993-10-19 |
Alza Corporation |
Process for lessening irritation caused by drug
|
US5200195A
(en)
*
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
US5200194A
(en)
*
|
1991-12-18 |
1993-04-06 |
Alza Corporation |
Oral osmotic device
|
US5543154A
(en)
*
|
1991-12-27 |
1996-08-06 |
Merck & Co., Inc. |
Controlled release nifedipine delivery device
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
US5248310A
(en)
*
|
1992-03-27 |
1993-09-28 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5512299A
(en)
*
|
1992-03-30 |
1996-04-30 |
Alza Corporation |
Method of treating oral inflammatory disease
|
US5869097A
(en)
*
|
1992-11-02 |
1999-02-09 |
Alza Corporation |
Method of therapy comprising an osmotic caplet
|
US5573776A
(en)
*
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5358721A
(en)
*
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5498255A
(en)
*
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
HU213407B
(en)
*
|
1993-12-09 |
1997-06-30 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing tablet with diffusive-osmotic release
|
US5474985A
(en)
*
|
1993-12-22 |
1995-12-12 |
The Regents Of The University Of California |
Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
|
GB9326267D0
(en)
*
|
1993-12-23 |
1994-02-23 |
Scherer Corp R P |
Expulsion of material
|
US5532003A
(en)
*
|
1994-01-18 |
1996-07-02 |
Alza Corporation |
Pentoxifylline therapy
|
US5540665A
(en)
*
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
US5698224A
(en)
*
|
1994-06-27 |
1997-12-16 |
Alza Corporation |
Tacrine therapy
|
US5460826A
(en)
*
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5529787A
(en)
*
|
1994-07-07 |
1996-06-25 |
Alza Corporation |
Hydromorphone therapy
|
US5633011A
(en)
*
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
IE70735B1
(en)
*
|
1994-08-15 |
1996-12-11 |
Elan Med Tech |
Orally administrable delivery device
|
US5837276A
(en)
*
|
1994-09-02 |
1998-11-17 |
Delab |
Apparatus for the delivery of elongate solid drug compositions
|
US5582591A
(en)
*
|
1994-09-02 |
1996-12-10 |
Delab |
Delivery of solid drug compositions
|
US6491945B1
(en)
*
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
US5614578A
(en)
*
|
1994-10-28 |
1997-03-25 |
Alza Corporation |
Injection-molded dosage form
|
US5582838A
(en)
*
|
1994-12-22 |
1996-12-10 |
Merck & Co., Inc. |
Controlled release drug suspension delivery device
|
US5534263A
(en)
|
1995-02-24 |
1996-07-09 |
Alza Corporation |
Active agent dosage form comprising a matrix and at least two insoluble bands
|
US5651979A
(en)
*
|
1995-03-30 |
1997-07-29 |
Gel Sciences, Inc. |
Apparatus and method for delivering a biologically active compound into a biological environment
|
US5876741A
(en)
*
|
1995-03-30 |
1999-03-02 |
Medlogic Global Corporation |
Chemo-mechanical expansion delivery system
|
SI9500173B
(sl)
*
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
US6262115B1
(en)
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
US5674895A
(en)
*
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
US6124355A
(en)
*
|
1995-05-22 |
2000-09-26 |
Guittard; George V. |
Oxybutynin therapy
|
US5817335A
(en)
*
|
1995-05-26 |
1998-10-06 |
Alza Corporation |
Osmotic device with high drug loading and delayed activation of drug delivery
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
US5713852A
(en)
*
|
1995-06-07 |
1998-02-03 |
Alza Corporation |
Oral dosage and method for treating painful conditions of the oral cavity
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5731001A
(en)
*
|
1995-06-07 |
1998-03-24 |
Magruder; Judy A. |
Locking couplings for osmotic delivery devices
|
US5780058A
(en)
*
|
1995-07-21 |
1998-07-14 |
Alza Corporation |
Oral delivery of discrete units
|
US5840332A
(en)
*
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
ES2168610T3
(es)
*
|
1996-03-12 |
2002-06-16 |
Alza Corp |
Composicion y forma galenica que contiene un antagonista opioide.
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
ZA97976B
(en)
*
|
1996-04-05 |
1997-08-18 |
Alza Corp |
Uniform drug delivery theraphy.
|
US5902605A
(en)
*
|
1996-04-18 |
1999-05-11 |
Alza Corporation |
Drug delivery device with minimal residual drug retention
|
CN101518517B
(zh)
*
|
1996-08-16 |
2014-11-26 |
阿尔萨公司 |
药物剂量逐渐增加的剂型
|
DK0936894T3
(da)
|
1996-10-18 |
2001-11-19 |
Alza Corp |
Indretning til afgivelse af aktivt middel
|
ATE202272T1
(de)
*
|
1996-10-18 |
2001-07-15 |
Alza Corp |
Vorrichtung mit mehreren strömungspfaden zur oralen verabreichung von boluseinheiten
|
US6024721A
(en)
|
1996-10-18 |
2000-02-15 |
Alza Corporation |
Mixing system for an active agent delivery device
|
CA2269707C
(en)
*
|
1996-10-25 |
2005-08-16 |
Edward M. Rudnic |
Soluble form osmotic dose delivery system
|
US6361796B1
(en)
*
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
EP0946151B1
(de)
*
|
1996-11-25 |
2006-05-10 |
Alza Corporation |
Dosisform mit ansteigender dosisfreisetzung
|
EP1782798A3
(de)
|
1996-11-25 |
2008-05-21 |
Alza Corporation |
Darreichungsform mit ansteigender Dosisfreisetzung
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
US5922352A
(en)
*
|
1997-01-31 |
1999-07-13 |
Andrx Pharmaceuticals, Inc. |
Once daily calcium channel blocker tablet having a delayed release core
|
US5837379A
(en)
*
|
1997-01-31 |
1998-11-17 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US20030100532A1
(en)
*
|
1997-02-14 |
2003-05-29 |
Gary S. Jacob |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
|
US5948787A
(en)
*
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
ATE221762T1
(de)
*
|
1997-05-16 |
2002-08-15 |
Alza Corp |
Durchflussreglerkonfigurationen für ein wirkstoff abgebendes gerät
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
US7060734B1
(en)
|
1997-09-09 |
2006-06-13 |
Alza Corporation |
Pharmaceutical coating composition and method of use
|
PT1014951E
(pt)
|
1997-09-09 |
2005-03-31 |
Alza Corp |
Composicao de revestimento farmaceutica e metodo para a sua utilizacao
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
CA2309321A1
(en)
|
1997-11-10 |
1999-05-20 |
G.D. Searle & Co. |
Use of alkylated iminosugars to treat multidrug resistance
|
ATE216220T1
(de)
|
1997-12-05 |
2002-05-15 |
Alza Corp |
Osmotische darreichungsform mit zwei mantelschichten
|
US6485748B1
(en)
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
CA2315890C
(en)
|
1997-12-22 |
2009-08-11 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
ES2272054T3
(es)
|
1998-02-12 |
2007-04-16 |
United Therapeutics Corporation |
Uso de compuestos de n-sustituido-1,5-didesoxi-1,5-imino-d-glucitol para tratar infecciones por el virus de la hepatitis.
|
US6134461A
(en)
|
1998-03-04 |
2000-10-17 |
E. Heller & Company |
Electrochemical analyte
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
AR018321A1
(es)
*
|
1998-03-26 |
2001-11-14 |
Alza Corp |
Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
|
US6949816B2
(en)
|
2003-04-21 |
2005-09-27 |
Motorola, Inc. |
Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
|
US8346337B2
(en)
|
1998-04-30 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8688188B2
(en)
|
1998-04-30 |
2014-04-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8974386B2
(en)
|
1998-04-30 |
2015-03-10 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8465425B2
(en)
|
1998-04-30 |
2013-06-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6175752B1
(en)
|
1998-04-30 |
2001-01-16 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US9066695B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8480580B2
(en)
|
1998-04-30 |
2013-07-09 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6365183B1
(en)
*
|
1998-05-07 |
2002-04-02 |
Alza Corporation |
Method of fabricating a banded prolonged release active agent dosage form
|
KR100827254B1
(ko)
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
US7890176B2
(en)
*
|
1998-07-06 |
2011-02-15 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating chronic pelvic pain
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
US7303768B2
(en)
*
|
1998-07-24 |
2007-12-04 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
US7772220B2
(en)
*
|
2004-10-15 |
2010-08-10 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
US20050158408A1
(en)
*
|
1998-07-24 |
2005-07-21 |
Yoo Seo H. |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
ID29632A
(id)
|
1998-07-24 |
2001-09-06 |
Seo Hong Yoo |
Pembuatan bentuk-bentuk dosis larutan bening berair dengan asam-asam empedu
|
EP1112060B1
(de)
*
|
1998-09-09 |
2005-12-07 |
ALZA Corporation |
Dosierungsform mit flüssiger formulierung
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US6087396A
(en)
*
|
1998-10-05 |
2000-07-11 |
Situs Corporation |
Oxybutynin formulations and method of use
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
ES2213404T3
(es)
|
1998-12-17 |
2004-08-16 |
Alza Corporation |
Transformacion de capsulas de gelatina rellenas de liquido en sistemas de liberacion controlada mediante multiples revestimientos.
|
CA2354621C
(en)
|
1998-12-18 |
2009-09-29 |
Alza Corporation |
Transparent transdermal nicotine delivery devices
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
CA2358296A1
(en)
*
|
1999-01-05 |
2000-07-13 |
Anthony P. Adamis |
Targeted transscleral controlled release drug delivery to the retina and choroid
|
EP1027888B1
(de)
|
1999-02-10 |
2009-06-10 |
Pfizer Products Inc. |
Osmotisches System zur Verabreichung von Wirkstoffen, die feste amorphe Dispersionen enthalten
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
US6545021B1
(en)
*
|
1999-02-12 |
2003-04-08 |
G.D. Searle & Co. |
Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
|
EP1173161A2
(de)
|
1999-02-12 |
2002-01-23 |
G.D. SEARLE & CO. |
Verwendung von glucamin derivaten zur behandlung von hepatitis infektionen
|
US6210716B1
(en)
|
1999-02-26 |
2001-04-03 |
Andrx Pharmaceuticals, Inc. |
Controlled release bupropion formulation
|
US8545880B2
(en)
*
|
1999-02-26 |
2013-10-01 |
Andrx Pharmaceuticals, Llc |
Controlled release oral dosage form
|
US6198966B1
(en)
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
WO2002043800A2
(en)
*
|
2000-11-29 |
2002-06-06 |
Durect Corporation |
Devices and methods for controlled delivery from a drug delivery device
|
US6541021B1
(en)
*
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
US6835194B2
(en)
*
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217896B1
(en)
*
|
1999-04-01 |
2001-04-17 |
Uab Research Foundation |
Conjunctival inserts for topical delivery of medication or lubrication
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
US6287870B1
(en)
*
|
1999-08-20 |
2001-09-11 |
Robert A. Levine |
Method and assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
CO5210862A1
(es)
|
1999-09-15 |
2002-10-30 |
Alza Corp |
Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
|
US6387325B1
(en)
*
|
1999-10-08 |
2002-05-14 |
Becton Dickinson & Company |
Assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
DE60018777T2
(de)
|
1999-10-21 |
2006-02-02 |
Alcon Inc. |
Medikamentenversorgung der sub-tenon
|
ES2315598T3
(es)
|
1999-10-21 |
2009-04-01 |
Alcon, Inc. |
Dispositivo para la administracion de farmacos.
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
DK1242055T3
(da)
|
1999-12-23 |
2008-07-21 |
Pfizer Prod Inc |
Hydrogelstyret doseringsform til lægemidler
|
JP2003518487A
(ja)
|
1999-12-23 |
2003-06-10 |
ファイザー・プロダクツ・インク |
ヒドロゲル駆動型積層薬物製剤
|
DE19962924A1
(de)
*
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
US6669954B2
(en)
|
2000-01-25 |
2003-12-30 |
John R. Crison |
Controlled release of drugs
|
JP2004500378A
(ja)
*
|
2000-02-04 |
2004-01-08 |
ヨー、セオ、ホン |
胆汁酸を含有する清浄水溶液製型の製造
|
CN1422156A
(zh)
*
|
2000-02-14 |
2003-06-04 |
法马西亚公司 |
N-取代的-1,5-二脱氧-1,5-亚氨基-d-葡萄糖醇化合物在治疗肝炎病毒感染中的用途
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6582441B1
(en)
|
2000-02-24 |
2003-06-24 |
Advanced Bionics Corporation |
Surgical insertion tool
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US7989436B2
(en)
*
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US6660726B2
(en)
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
AU2001257359A1
(en)
|
2000-04-27 |
2001-11-07 |
Verion Inc. |
Zero order release and temperature-controlled microcapsules and process for the preparation thereof
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
US20030086972A1
(en)
*
|
2000-08-09 |
2003-05-08 |
Appel Leah E. |
Hydrogel-driven drug dosage form
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
DE60114229T2
(de)
*
|
2000-11-29 |
2006-07-06 |
Allergan, Inc., Irvine |
Verhinderung von transplantatabstossung im auge
|
US6560471B1
(en)
|
2001-01-02 |
2003-05-06 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US20050143789A1
(en)
*
|
2001-01-30 |
2005-06-30 |
Whitehurst Todd K. |
Methods and systems for stimulating a peripheral nerve to treat chronic pain
|
US20060064140A1
(en)
*
|
2001-01-30 |
2006-03-23 |
Whitehurst Todd K |
Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
|
US7493172B2
(en)
*
|
2001-01-30 |
2009-02-17 |
Boston Scientific Neuromodulation Corp. |
Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
|
IN190699B
(de)
|
2001-02-02 |
2003-08-16 |
Sun Pharmaceutical Ind Ltd |
|
EP1372614A4
(de)
*
|
2001-03-16 |
2007-10-31 |
Andrx Pharmaceuticals Llc |
Sulfonylharnstoff-formulierung mit kontrollierter freisetzung
|
EP1397068A2
(de)
|
2001-04-02 |
2004-03-17 |
Therasense, Inc. |
Gerät und verfahren zur blutzuckerverfolgung
|
US6632217B2
(en)
*
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
US7563255B2
(en)
|
2001-05-03 |
2009-07-21 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
WO2002100318A2
(en)
|
2001-06-12 |
2002-12-19 |
Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
DE10129725A1
(de)
*
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US20040180087A1
(en)
*
|
2001-06-21 |
2004-09-16 |
Boyong Li |
Stable controlled release pharmaceutical compositions containing pravastatin
|
DE60214697T2
(de)
*
|
2001-07-23 |
2007-09-13 |
Alcon Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
PT1409065E
(pt)
|
2001-07-23 |
2007-03-30 |
Alcon Inc |
Dispositivo de administração de fármacos oftálmicos
|
US20030091634A1
(en)
*
|
2001-09-14 |
2003-05-15 |
Pawan Seth |
Delayed release tablet of venlafaxin
|
JP2005508325A
(ja)
*
|
2001-09-28 |
2005-03-31 |
マクニール−ピーピーシー・インコーポレイテッド |
内側コア及び外側シェルを有する投薬形態
|
US20030153864A1
(en)
*
|
2001-10-16 |
2003-08-14 |
Bernard Chaffringeon |
Disposable device and method for transferring an active liquid into a body cavity
|
US8329217B2
(en)
|
2001-11-06 |
2012-12-11 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dual controlled release dosage form
|
US20030185882A1
(en)
*
|
2001-11-06 |
2003-10-02 |
Vergez Juan A. |
Pharmaceutical compositions containing oxybutynin
|
US7183321B2
(en)
*
|
2001-12-17 |
2007-02-27 |
Bristol-Myers Squibb Company |
Antidiabetic formulation and method
|
US20030175346A1
(en)
*
|
2002-02-01 |
2003-09-18 |
Anne Billotte |
Osmotic delivery system
|
US20030161882A1
(en)
*
|
2002-02-01 |
2003-08-28 |
Waterman Kenneth C. |
Osmotic delivery system
|
US7613491B2
(en)
|
2002-05-22 |
2009-11-03 |
Dexcom, Inc. |
Silicone based membranes for use in implantable glucose sensors
|
US8260393B2
(en)
|
2003-07-25 |
2012-09-04 |
Dexcom, Inc. |
Systems and methods for replacing signal data artifacts in a glucose sensor data stream
|
US8364229B2
(en)
|
2003-07-25 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US9247901B2
(en)
|
2003-08-22 |
2016-02-02 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8010174B2
(en)
|
2003-08-22 |
2011-08-30 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
EP1490090A4
(de)
|
2002-02-22 |
2006-09-20 |
New River Pharmaceuticals Inc |
Wirkstoff-abgabesystem und verfahren zum schutz und zur verabreichung von wirkstoffen
|
US7514107B2
(en)
|
2002-03-21 |
2009-04-07 |
Mars, Incorporated |
Treatment of diseases involving defective gap junctional communication
|
CA2481091A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Penwest Pharmaceuticals Co. |
Sustained release metoprolol formulations
|
US7125563B2
(en)
*
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
US6733526B2
(en)
|
2002-04-25 |
2004-05-11 |
Advanced Medical Optics, Inc. |
Method of improving adherence and centering of intra-corneal implants on corneal bed
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
CN1665482A
(zh)
*
|
2002-04-29 |
2005-09-07 |
阿尔扎公司 |
羟可待酮控制输送给药的方法和剂型
|
AU2003217531A1
(en)
*
|
2002-05-02 |
2003-11-17 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
US7328706B2
(en)
*
|
2002-05-06 |
2008-02-12 |
Dynamic Mouth Devices Llc |
Therapeutic and protective dental device useful as an intra-oral delivery system
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7151961B1
(en)
*
|
2002-05-24 |
2006-12-19 |
Advanced Bionics Corporation |
Treatment of movement disorders by brain stimulation
|
WO2003101384A2
(en)
*
|
2002-05-31 |
2003-12-11 |
Alza Corporation |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
US20040043067A1
(en)
*
|
2002-06-19 |
2004-03-04 |
Salamone Joseph C. |
Fluorosiloxane matrix controlled diffusion drug delivery systems
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20040115262A1
(en)
*
|
2002-07-29 |
2004-06-17 |
Frank Jao |
Formulations and dosage forms for controlled delivery of topiramate
|
US20050175697A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Novel drug compositions and dosage forms of topiramate
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US7254449B2
(en)
*
|
2002-07-31 |
2007-08-07 |
Advanced Bionics Corp |
Systems and methods for providing power to one or more implantable devices
|
CA2497867A1
(en)
|
2002-09-06 |
2004-03-18 |
Durect Corporation |
Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
|
US20060009739A1
(en)
*
|
2002-09-06 |
2006-01-12 |
Durect Corporation |
Implantable flow regulator with failsafe mode and reserve drug supply
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
HUE038446T2
(hu)
|
2002-09-20 |
2018-10-29 |
Alpharma Pharmaceuticals Llc |
Szekvesztráló alegység és releváns kompozíciók és módszerek
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
EP1556017A1
(de)
*
|
2002-10-31 |
2005-07-27 |
ALZA Corporation |
Dosierungsform mit steigender freisetzung einer flüssigen formulierung
|
US7381184B2
(en)
|
2002-11-05 |
2008-06-03 |
Abbott Diabetes Care Inc. |
Sensor inserter assembly
|
GB2395126A
(en)
|
2002-11-09 |
2004-05-19 |
Reckitt Benckiser |
Volatile substance dispenser
|
US6893660B2
(en)
*
|
2002-11-21 |
2005-05-17 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions without a stabilizer
|
US20040102476A1
(en)
*
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
JP4865330B2
(ja)
|
2002-12-13 |
2012-02-01 |
デュレクト コーポレーション |
経口ドラッグデリバリーシステム
|
US8771183B2
(en)
|
2004-02-17 |
2014-07-08 |
Abbott Diabetes Care Inc. |
Method and system for providing data communication in continuous glucose monitoring and management system
|
AU2003303597A1
(en)
|
2002-12-31 |
2004-07-29 |
Therasense, Inc. |
Continuous glucose monitoring system and methods of use
|
DE10300111A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
US20050048099A1
(en)
*
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
KR20050095835A
(ko)
*
|
2003-01-14 |
2005-10-04 |
알자 코포레이션 |
조정된 점성층을 갖는 방법 및 제형
|
JP3811127B2
(ja)
*
|
2003-01-30 |
2006-08-16 |
株式会社東芝 |
情報記録装置及び情報記録方法
|
CA2515641A1
(en)
*
|
2003-02-11 |
2004-08-26 |
Alza Corporation |
Methods and dosage forms with modified layer geometry
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
US6992075B2
(en)
*
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
EP1622623A4
(de)
*
|
2003-04-11 |
2009-03-18 |
Barr Lab Inc |
Verfahren zur verabreichung von östrogenen und gestagenen
|
US20040213850A1
(en)
*
|
2003-04-25 |
2004-10-28 |
Eleni Dokou |
Sustained release delivery of a thrombin inhibitor
|
US20070083240A1
(en)
*
|
2003-05-08 |
2007-04-12 |
Peterson David K L |
Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator
|
WO2005016241A2
(en)
|
2003-05-16 |
2005-02-24 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
US8066639B2
(en)
|
2003-06-10 |
2011-11-29 |
Abbott Diabetes Care Inc. |
Glucose measuring device for use in personal area network
|
US20040253293A1
(en)
*
|
2003-06-16 |
2004-12-16 |
Afshin Shafiee |
Rate controlled release of a pharmaceutical agent in a biodegradable device
|
US7145125B2
(en)
|
2003-06-23 |
2006-12-05 |
Advanced Optical Technologies, Llc |
Integrating chamber cone light using LED sources
|
CA2529984C
(en)
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
|
KR20060082792A
(ko)
*
|
2003-07-10 |
2006-07-19 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
US9763609B2
(en)
|
2003-07-25 |
2017-09-19 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US7761130B2
(en)
|
2003-07-25 |
2010-07-20 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US7774145B2
(en)
|
2003-08-01 |
2010-08-10 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7591801B2
(en)
|
2004-02-26 |
2009-09-22 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US7494465B2
(en)
|
2004-07-13 |
2009-02-24 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8275437B2
(en)
|
2003-08-01 |
2012-09-25 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US20190357827A1
(en)
|
2003-08-01 |
2019-11-28 |
Dexcom, Inc. |
Analyte sensor
|
US20050058707A1
(en)
*
|
2003-08-06 |
2005-03-17 |
Iran Reyes |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
US20140121989A1
(en)
|
2003-08-22 |
2014-05-01 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US8233959B2
(en)
|
2003-08-22 |
2012-07-31 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
EP1658048A2
(de)
*
|
2003-08-22 |
2006-05-24 |
ALZA Corporation |
Schrittweise abgabe von topiramat über einen längeren zeitraum
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US20050069587A1
(en)
*
|
2003-09-02 |
2005-03-31 |
Modi Nishit Bachulal |
Novel drug compositions and dosage forms of topiramate
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
CA2540056C
(en)
*
|
2003-09-26 |
2015-03-24 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
JP2007506775A
(ja)
|
2003-09-26 |
2007-03-22 |
アルザ・コーポレーシヨン |
漸増する放出速度を表す制御放出製剤
|
JP2007524652A
(ja)
*
|
2003-09-26 |
2007-08-30 |
アルザ・コーポレーシヨン |
アルプラゾラムの制御送達のための浸透性投薬形態物
|
EP1708684A2
(de)
*
|
2003-09-26 |
2006-10-11 |
Alza Corporation |
Arzneimittelbeschichtung mit hoher arzneimittelbeladung und verfahren dafür
|
US20050089570A1
(en)
*
|
2003-09-26 |
2005-04-28 |
Evangeline Cruz |
Oros push-stick for controlled delivery of active agents
|
WO2005040758A2
(en)
*
|
2003-10-24 |
2005-05-06 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
CA2543238A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption
|
US7299082B2
(en)
|
2003-10-31 |
2007-11-20 |
Abbott Diabetes Care, Inc. |
Method of calibrating an analyte-measurement device, and associated methods, devices and systems
|
US20050118246A1
(en)
*
|
2003-10-31 |
2005-06-02 |
Wong Patrick S. |
Dosage forms and layered deposition processes for fabricating dosage forms
|
USD914881S1
(en)
|
2003-11-05 |
2021-03-30 |
Abbott Diabetes Care Inc. |
Analyte sensor electronic mount
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20050250737A1
(en)
*
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
WO2005054297A2
(en)
|
2003-11-28 |
2005-06-16 |
Eastman Chemical Company |
Cellulose interpolymers and method of oxidation
|
US11633133B2
(en)
|
2003-12-05 |
2023-04-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US8423114B2
(en)
|
2006-10-04 |
2013-04-16 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
EP2256493B1
(de)
|
2003-12-05 |
2014-02-26 |
DexCom, Inc. |
Kalibrierverfahren für einen kontinuierlichen Analytsensor
|
US7769461B2
(en)
*
|
2003-12-19 |
2010-08-03 |
Boston Scientific Neuromodulation Corporation |
Skull-mounted electrical stimulation system and method for treating patients
|
EP1703894A1
(de)
*
|
2003-12-23 |
2006-09-27 |
ALZA Corporation |
Verfahren und dosierformen zur erhöhung der löslichkeit von arzneizusammensetzungen für kontrollierte abgabe
|
CA2551815A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation |
Novel drug compositions and dosage forms
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
JP2007518804A
(ja)
|
2004-01-20 |
2007-07-12 |
アラーガン、インコーポレイテッド |
トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物
|
WO2009048462A1
(en)
|
2007-10-09 |
2009-04-16 |
Dexcom, Inc. |
Integrated insulin delivery system with continuous glucose sensor
|
US8808228B2
(en)
|
2004-02-26 |
2014-08-19 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050226929A1
(en)
*
|
2004-04-12 |
2005-10-13 |
Jianbo Xie |
Controlled release opioid analgesic formulation
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US7799336B2
(en)
*
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US8147865B2
(en)
*
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
US7771742B2
(en)
*
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US8512738B2
(en)
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8722097B2
(en)
*
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
DE102004023069A1
(de)
|
2004-05-11 |
2005-12-08 |
Bayer Healthcare Ag |
Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
|
US20050267555A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Marnfeldt Goran N |
Engagement tool for implantable medical devices
|
WO2005119524A2
(en)
|
2004-06-04 |
2005-12-15 |
Therasense, Inc. |
Diabetes care host-client architecture and data management system
|
WO2006007323A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20080027513A1
(en)
*
|
2004-07-09 |
2008-01-31 |
Advanced Bionics Corporation |
Systems And Methods For Using A Butterfly Coil To Communicate With Or Transfer Power To An Implantable Medical Device
|
AU2005271700B2
(en)
*
|
2004-07-12 |
2010-11-11 |
Allergan, Inc. |
Opthalmic compositions and methods for treating ophthalmic conditions
|
US8886272B2
(en)
|
2004-07-13 |
2014-11-11 |
Dexcom, Inc. |
Analyte sensor
|
US8452368B2
(en)
|
2004-07-13 |
2013-05-28 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8565848B2
(en)
|
2004-07-13 |
2013-10-22 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7783333B2
(en)
|
2004-07-13 |
2010-08-24 |
Dexcom, Inc. |
Transcutaneous medical device with variable stiffness
|
US8170803B2
(en)
|
2004-07-13 |
2012-05-01 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US20070045902A1
(en)
|
2004-07-13 |
2007-03-01 |
Brauker James H |
Analyte sensor
|
US8452407B2
(en)
*
|
2004-08-16 |
2013-05-28 |
Boston Scientific Neuromodulation Corporation |
Methods for treating gastrointestinal disorders
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
DE602005019582D1
(de)
*
|
2004-08-30 |
2010-04-08 |
Seo Hong Yoo |
Nervenschutzwirkung von aufgelöster udca bei einem fokalen ischämischen modell
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
US7780981B2
(en)
|
2004-09-13 |
2010-08-24 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
JP2008516977A
(ja)
*
|
2004-10-15 |
2008-05-22 |
セオ ホン ユー |
薬剤学的化合物の毒性を減少させるための方法及び組成物
|
KR101358078B1
(ko)
*
|
2004-11-01 |
2014-02-06 |
주식회사 유스팜인터내셔널 |
근위축성 측삭 경화증의 신경퇴행을 감소시키기 위한 방법및 조성물
|
US9358393B1
(en)
|
2004-11-09 |
2016-06-07 |
Andres M. Lozano |
Stimulation methods and systems for treating an auditory dysfunction
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
US7483746B2
(en)
*
|
2004-12-06 |
2009-01-27 |
Boston Scientific Neuromodulation Corp. |
Stimulation of the stomach in response to sensed parameters to treat obesity
|
US9327069B2
(en)
|
2004-12-21 |
2016-05-03 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a medical condition by promoting neural remodeling within the brain
|
US20060161217A1
(en)
*
|
2004-12-21 |
2006-07-20 |
Jaax Kristen N |
Methods and systems for treating obesity
|
US20070038264A1
(en)
*
|
2004-12-21 |
2007-02-15 |
Jaax Kristen N |
Methods and systems for treating autism
|
US9095713B2
(en)
*
|
2004-12-21 |
2015-08-04 |
Allison M. Foster |
Methods and systems for treating autism by decreasing neural activity within the brain
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US8515541B1
(en)
|
2004-12-22 |
2013-08-20 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating post-stroke disorders
|
EP1819325A2
(de)
*
|
2004-12-22 |
2007-08-22 |
Alcon, Inc. |
Vorrichtung zur verabreichung ophthalmischer arzneimittel
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US9352145B2
(en)
*
|
2004-12-22 |
2016-05-31 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a psychotic disorder
|
US7883464B2
(en)
|
2005-09-30 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Integrated transmitter unit and sensor introducer mechanism and methods of use
|
US9259175B2
(en)
|
2006-10-23 |
2016-02-16 |
Abbott Diabetes Care, Inc. |
Flexible patch for fluid delivery and monitoring body analytes
|
US8571624B2
(en)
|
2004-12-29 |
2013-10-29 |
Abbott Diabetes Care Inc. |
Method and apparatus for mounting a data transmission device in a communication system
|
US8333714B2
(en)
|
2006-09-10 |
2012-12-18 |
Abbott Diabetes Care Inc. |
Method and system for providing an integrated analyte sensor insertion device and data processing unit
|
US8512243B2
(en)
|
2005-09-30 |
2013-08-20 |
Abbott Diabetes Care Inc. |
Integrated introducer and transmitter assembly and methods of use
|
US9398882B2
(en)
|
2005-09-30 |
2016-07-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor and data processing device
|
US7731657B2
(en)
|
2005-08-30 |
2010-06-08 |
Abbott Diabetes Care Inc. |
Analyte sensor introducer and methods of use
|
US20090105569A1
(en)
|
2006-04-28 |
2009-04-23 |
Abbott Diabetes Care, Inc. |
Introducer Assembly and Methods of Use
|
US9788771B2
(en)
|
2006-10-23 |
2017-10-17 |
Abbott Diabetes Care Inc. |
Variable speed sensor insertion devices and methods of use
|
US9572534B2
(en)
|
2010-06-29 |
2017-02-21 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
US9636450B2
(en)
|
2007-02-19 |
2017-05-02 |
Udo Hoss |
Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
|
US8545403B2
(en)
|
2005-12-28 |
2013-10-01 |
Abbott Diabetes Care Inc. |
Medical device insertion
|
US9351669B2
(en)
|
2009-09-30 |
2016-05-31 |
Abbott Diabetes Care Inc. |
Interconnect for on-body analyte monitoring device
|
US10226207B2
(en)
|
2004-12-29 |
2019-03-12 |
Abbott Diabetes Care Inc. |
Sensor inserter having introducer
|
US9743862B2
(en)
|
2011-03-31 |
2017-08-29 |
Abbott Diabetes Care Inc. |
Systems and methods for transcutaneously implanting medical devices
|
US8029441B2
(en)
|
2006-02-28 |
2011-10-04 |
Abbott Diabetes Care Inc. |
Analyte sensor transmitter unit configuration for a data monitoring and management system
|
US7697967B2
(en)
|
2005-12-28 |
2010-04-13 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
IL166114A0
(en)
*
|
2005-01-03 |
2006-01-15 |
Calcident Active Ltd |
Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
|
EP1858492B1
(de)
*
|
2005-01-27 |
2008-11-12 |
ALZA Corporation |
Orale osmotische darreichungsform mit membran mit hoher flussdichte
|
EP1685841A1
(de)
*
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prophylaxe und Behandlung von thrombolischen Erkrankungen
|
WO2006084082A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Compositions of unconjugated estrogens and methods for their use
|
CA2596933A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Devices for delivering agents to a vaginal tract
|
EP1690540A1
(de)
*
|
2005-02-15 |
2006-08-16 |
Neuro3D |
Zusammensetzung enthaltend Ocaperidon
|
US20060185665A1
(en)
*
|
2005-02-22 |
2006-08-24 |
Bachinski Thomas J |
Sauna fireplace
|
US20060194724A1
(en)
*
|
2005-02-25 |
2006-08-31 |
Whitehurst Todd K |
Methods and systems for nerve regeneration
|
US20060204548A1
(en)
*
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
US8423155B1
(en)
|
2005-03-14 |
2013-04-16 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US7848803B1
(en)
|
2005-03-14 |
2010-12-07 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US7853321B2
(en)
*
|
2005-03-14 |
2010-12-14 |
Boston Scientific Neuromodulation Corporation |
Stimulation of a stimulation site within the neck or head
|
US7702385B2
(en)
*
|
2005-11-16 |
2010-04-20 |
Boston Scientific Neuromodulation Corporation |
Electrode contact configurations for an implantable stimulator
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
CN101232868A
(zh)
*
|
2005-04-19 |
2008-07-30 |
阿尔扎公司 |
曲马多和加巴喷丁的控释递药剂型
|
US8112240B2
(en)
|
2005-04-29 |
2012-02-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing leak detection in data monitoring and management systems
|
US7931909B2
(en)
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
CN101291652A
(zh)
*
|
2005-06-29 |
2008-10-22 |
阿尔扎公司 |
对渗透剂型提供降低的干燥时间的半渗透性组合物
|
DE102005031577A1
(de)
*
|
2005-07-06 |
2007-01-11 |
Bayer Healthcare Ag |
Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
|
GB2442396B
(en)
*
|
2005-07-22 |
2011-05-11 |
Univ Utah Res Found |
Osmotically driven dispense pump and related components for use in high pressure applications
|
NZ565953A
(en)
|
2005-07-27 |
2012-01-12 |
Univ Florida |
Small compounds that correct protein misfolding and uses thereof
|
JP2009507774A
(ja)
*
|
2005-08-04 |
2009-02-26 |
アルザ・コーポレーシヨン |
改良された性質を提供するポリマー混合物による半透過性膜を含んでなる浸透性用量形態物
|
US8778395B2
(en)
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
US20070048347A1
(en)
|
2005-08-26 |
2007-03-01 |
Laura Bardach |
Intra-oral device for treating obesity
|
JP2009507224A
(ja)
|
2005-08-31 |
2009-02-19 |
ユニヴァーシティー オブ ヴァージニア パテント ファンデーション |
連続グルコースセンサの精度の改善
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
US7684858B2
(en)
*
|
2005-09-21 |
2010-03-23 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for placing an implanted stimulator for stimulating tissue
|
DE102005045518A1
(de)
*
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
US8182841B2
(en)
|
2005-09-27 |
2012-05-22 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-inflammation methods
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
US9521968B2
(en)
|
2005-09-30 |
2016-12-20 |
Abbott Diabetes Care Inc. |
Analyte sensor retention mechanism and methods of use
|
US8880138B2
(en)
|
2005-09-30 |
2014-11-04 |
Abbott Diabetes Care Inc. |
Device for channeling fluid and methods of use
|
DE102005047558A1
(de)
*
|
2005-10-04 |
2008-02-07 |
Bayer Healthcare Ag |
Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
AU2006299126B2
(en)
|
2005-10-04 |
2012-06-28 |
Bayer Intellectual Property Gmbh |
Novel polymorphous form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
|
WO2007044234A1
(en)
*
|
2005-10-07 |
2007-04-19 |
Alza Corporation |
Osmotic dosage form with controlled release and fast release aspects
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US7766829B2
(en)
|
2005-11-04 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and system for providing basal profile modification in analyte monitoring and management systems
|
EP1948246B1
(de)
|
2005-11-14 |
2017-05-03 |
Theragene Pharmaceuticals, Inc. |
Stammzellenfaktor-therapie für gewebeverletzungen
|
KR101405545B1
(ko)
|
2005-11-28 |
2014-07-03 |
마리누스 파마슈티컬스 |
ganaxolone 제형, 이의 제조방법 및 용도
|
MX2008006379A
(es)
|
2005-11-29 |
2009-03-03 |
Smithkline Beecham Corp |
Metodo de tratamiento.
|
US7729758B2
(en)
*
|
2005-11-30 |
2010-06-01 |
Boston Scientific Neuromodulation Corporation |
Magnetically coupled microstimulators
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US11298058B2
(en)
|
2005-12-28 |
2022-04-12 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
US7610100B2
(en)
*
|
2005-12-30 |
2009-10-27 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating osteoarthritis
|
US7835803B1
(en)
*
|
2006-01-17 |
2010-11-16 |
Boston Scientific Neuromodulation Corporation |
Lead assemblies with one or more switching networks
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US7736310B2
(en)
|
2006-01-30 |
2010-06-15 |
Abbott Diabetes Care Inc. |
On-body medical device securement
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
US7826879B2
(en)
|
2006-02-28 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Analyte sensors and methods of use
|
US7885698B2
(en)
|
2006-02-28 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Method and system for providing continuous calibration of implantable analyte sensors
|
US8309104B2
(en)
|
2006-03-02 |
2012-11-13 |
Watson Pharmaceuticals, Inc. |
Oral controlled release formulation for sedative and hypnotic agents
|
US8175710B2
(en)
*
|
2006-03-14 |
2012-05-08 |
Boston Scientific Neuromodulation Corporation |
Stimulator system with electrode array and the method of making the same
|
US7777641B2
(en)
*
|
2006-03-29 |
2010-08-17 |
Advanced Bionics, Llc |
Systems and methods of facilitating communication between a first and second device
|
US8478557B2
(en)
|
2009-07-31 |
2013-07-02 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte monitoring system calibration accuracy
|
US9326709B2
(en)
|
2010-03-10 |
2016-05-03 |
Abbott Diabetes Care Inc. |
Systems, devices and methods for managing glucose levels
|
US7653425B2
(en)
|
2006-08-09 |
2010-01-26 |
Abbott Diabetes Care Inc. |
Method and system for providing calibration of an analyte sensor in an analyte monitoring system
|
US7801582B2
(en)
|
2006-03-31 |
2010-09-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management system and methods therefor
|
US7620438B2
(en)
|
2006-03-31 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for powering an electronic device
|
US8473022B2
(en)
|
2008-01-31 |
2013-06-25 |
Abbott Diabetes Care Inc. |
Analyte sensor with time lag compensation
|
US8219173B2
(en)
|
2008-09-30 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Optimizing analyte sensor calibration
|
US9675290B2
(en)
|
2012-10-30 |
2017-06-13 |
Abbott Diabetes Care Inc. |
Sensitivity calibration of in vivo sensors used to measure analyte concentration
|
US9392969B2
(en)
|
2008-08-31 |
2016-07-19 |
Abbott Diabetes Care Inc. |
Closed loop control and signal attenuation detection
|
US8140312B2
(en)
|
2007-05-14 |
2012-03-20 |
Abbott Diabetes Care Inc. |
Method and system for determining analyte levels
|
US8346335B2
(en)
|
2008-03-28 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte sensor calibration management
|
US8374668B1
(en)
|
2007-10-23 |
2013-02-12 |
Abbott Diabetes Care Inc. |
Analyte sensor with lag compensation
|
US8224415B2
(en)
|
2009-01-29 |
2012-07-17 |
Abbott Diabetes Care Inc. |
Method and device for providing offset model based calibration for analyte sensor
|
US7630748B2
(en)
|
2006-10-25 |
2009-12-08 |
Abbott Diabetes Care Inc. |
Method and system for providing analyte monitoring
|
US9339217B2
(en)
|
2011-11-25 |
2016-05-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods of use
|
US8226891B2
(en)
|
2006-03-31 |
2012-07-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods therefor
|
US7618369B2
(en)
|
2006-10-02 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for dynamically updating calibration parameters for an analyte sensor
|
US9561188B2
(en)
*
|
2006-04-03 |
2017-02-07 |
Intellipharmaceutics Corporation |
Controlled release delivery device comprising an organosol coat
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
WO2007121188A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
PL2026803T3
(pl)
*
|
2006-05-16 |
2012-05-31 |
Knopp Neurosciences Inc |
Kompozycje R(+) i S(-) pramipeksolu i sposoby ich zastosowania
|
US7920907B2
(en)
|
2006-06-07 |
2011-04-05 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and method
|
EP2484346B1
(de)
*
|
2006-06-19 |
2017-02-22 |
Alpharma Pharmaceuticals LLC |
Pharmazeutische Zusammensetzungen
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8401654B1
(en)
|
2006-06-30 |
2013-03-19 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating one or more effects of deafferentation
|
US8504163B1
(en)
|
2006-06-30 |
2013-08-06 |
Boston Scientific Neuromodulation Corporation |
Cranially mounted stimulation systems and methods
|
CA2657435A1
(en)
|
2006-07-10 |
2008-07-03 |
Medipacs, Inc. |
Super elastic epoxy hydrogel
|
EP2056818B1
(de)
|
2006-08-11 |
2011-05-25 |
The Johns Hopkins University |
Zusammensetzungen und verfahren für nervenschutz
|
KR20090057035A
(ko)
*
|
2006-08-21 |
2009-06-03 |
유나이티드 세러퓨틱스 코오포레이션 |
바이러스 감염의 치료를 위한 병용 요법
|
DK2526934T3
(en)
|
2006-09-22 |
2016-03-07 |
Pharmacyclics Llc |
Inhibitors of Bruton's tyrosine kinase
|
US7445528B1
(en)
|
2006-09-29 |
2008-11-04 |
Boston Scientific Neuromodulation Corporation |
Connector assemblies
|
CN101636104B
(zh)
|
2006-10-26 |
2012-07-18 |
雅培糖尿病护理公司 |
实时检测分析物传感器灵敏度下降的方法及系统
|
US7347746B1
(en)
|
2006-10-27 |
2008-03-25 |
Boston Scientific Neuromodulation Corporation |
Receptacle connector assembly
|
DE102006051625A1
(de)
*
|
2006-11-02 |
2008-05-08 |
Bayer Materialscience Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US8586556B2
(en)
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
EP2091482A2
(de)
|
2006-12-01 |
2009-08-26 |
Allergan, Inc. |
Verfahren zur bestimmung optimaler intraokularer standorte für systeme zur verabreichung von medikamenten
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
US8846073B2
(en)
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
US20090011018A1
(en)
*
|
2006-12-28 |
2009-01-08 |
Astellas Pharma Inc., |
Sustained release formulation for tacrolimus
|
WO2008089260A2
(en)
*
|
2007-01-16 |
2008-07-24 |
Victory Pharma, Inc. |
Combined administration of benzonatate and guaifenesin
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
US8121857B2
(en)
|
2007-02-15 |
2012-02-21 |
Abbott Diabetes Care Inc. |
Device and method for automatic data acquisition and/or detection
|
US20080199894A1
(en)
|
2007-02-15 |
2008-08-21 |
Abbott Diabetes Care, Inc. |
Device and method for automatic data acquisition and/or detection
|
US8732188B2
(en)
|
2007-02-18 |
2014-05-20 |
Abbott Diabetes Care Inc. |
Method and system for providing contextual based medication dosage determination
|
US8930203B2
(en)
|
2007-02-18 |
2015-01-06 |
Abbott Diabetes Care Inc. |
Multi-function analyte test device and methods therefor
|
US8123686B2
(en)
|
2007-03-01 |
2012-02-28 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing rolling data in communication systems
|
JP2010521496A
(ja)
|
2007-03-14 |
2010-06-24 |
ノップ ニューロサイエンシーズ、インク. |
キラル精製置換ベンゾチアゾールジアミンの合成
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
EP2146623B1
(de)
|
2007-04-14 |
2014-01-08 |
Abbott Diabetes Care Inc. |
Verfahren und vorrichtung zur datenverarbeitung und steuerung in einem medizinischen kommunikationssystem
|
EP2146624B1
(de)
|
2007-04-14 |
2020-03-25 |
Abbott Diabetes Care Inc. |
Verfahren und vorrichtung zur datenverarbeitung und steuerung in einem medizinischen kommunikationssystem
|
EP2146622B1
(de)
|
2007-04-14 |
2016-05-11 |
Abbott Diabetes Care Inc. |
Verfahren und vorrichtung für dynamische mehrstufige signalverstärkung bei einer medizinischen vorrichtung
|
CA2683962C
(en)
|
2007-04-14 |
2017-06-06 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
CA2683930A1
(en)
|
2007-04-14 |
2008-10-23 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
ES2817503T3
(es)
|
2007-04-14 |
2021-04-07 |
Abbott Diabetes Care Inc |
Procedimiento y aparato para proporcionar el procesamiento y control de datos en un sistema de comunicación médica
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
US8461985B2
(en)
|
2007-05-08 |
2013-06-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US7928850B2
(en)
|
2007-05-08 |
2011-04-19 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8665091B2
(en)
|
2007-05-08 |
2014-03-04 |
Abbott Diabetes Care Inc. |
Method and device for determining elapsed sensor life
|
US8456301B2
(en)
|
2007-05-08 |
2013-06-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8239166B2
(en)
|
2007-05-14 |
2012-08-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US10002233B2
(en)
|
2007-05-14 |
2018-06-19 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US7996158B2
(en)
|
2007-05-14 |
2011-08-09 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8260558B2
(en)
|
2007-05-14 |
2012-09-04 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8560038B2
(en)
|
2007-05-14 |
2013-10-15 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US9125548B2
(en)
|
2007-05-14 |
2015-09-08 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8444560B2
(en)
|
2007-05-14 |
2013-05-21 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8103471B2
(en)
|
2007-05-14 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8600681B2
(en)
|
2007-05-14 |
2013-12-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US20200037875A1
(en)
|
2007-05-18 |
2020-02-06 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
WO2008150917A1
(en)
|
2007-05-31 |
2008-12-11 |
Abbott Diabetes Care, Inc. |
Insertion devices and methods
|
AU2008262018A1
(en)
|
2007-06-08 |
2008-12-18 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
AU2008265541B2
(en)
|
2007-06-21 |
2014-07-17 |
Abbott Diabetes Care, Inc. |
Health management devices and methods
|
WO2008157821A1
(en)
|
2007-06-21 |
2008-12-24 |
Abbott Diabetes Care, Inc. |
Health monitor
|
US8160900B2
(en)
|
2007-06-29 |
2012-04-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
|
US7768386B2
(en)
|
2007-07-31 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8834366B2
(en)
|
2007-07-31 |
2014-09-16 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor calibration
|
US8748648B2
(en)
*
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
CN101854933A
(zh)
|
2007-09-10 |
2010-10-06 |
钙医学公司 |
调节细胞内钙的化合物
|
US20090088681A1
(en)
*
|
2007-10-02 |
2009-04-02 |
Mcintyre Jon T |
Device and method for the treatment of intra-abdominal disease
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
US8216138B1
(en)
|
2007-10-23 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
|
US8377031B2
(en)
|
2007-10-23 |
2013-02-19 |
Abbott Diabetes Care Inc. |
Closed loop control system with safety parameters and methods
|
US8409093B2
(en)
|
2007-10-23 |
2013-04-02 |
Abbott Diabetes Care Inc. |
Assessing measures of glycemic variability
|
US9995295B2
(en)
*
|
2007-12-03 |
2018-06-12 |
Medipacs, Inc. |
Fluid metering device
|
WO2009088414A2
(en)
|
2007-12-06 |
2009-07-16 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20090164239A1
(en)
|
2007-12-19 |
2009-06-25 |
Abbott Diabetes Care, Inc. |
Dynamic Display Of Glucose Information
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
MX2010008861A
(es)
*
|
2008-02-15 |
2011-02-22 |
Sun Pharma Advanced Res Co Ltd |
Tableta oral de liberacion controlada con efecto de liberacion masiva reducido.
|
US8252229B2
(en)
|
2008-04-10 |
2012-08-28 |
Abbott Diabetes Care Inc. |
Method and system for sterilizing an analyte sensor
|
US8591410B2
(en)
|
2008-05-30 |
2013-11-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
US7826382B2
(en)
|
2008-05-30 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Close proximity communication device and methods
|
US8924159B2
(en)
|
2008-05-30 |
2014-12-30 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
US8876755B2
(en)
|
2008-07-14 |
2014-11-04 |
Abbott Diabetes Care Inc. |
Closed loop control system interface and methods
|
WO2010022140A1
(en)
|
2008-08-19 |
2010-02-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (r)-pramipexole
|
CA2734500A1
(en)
|
2008-08-27 |
2010-03-11 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
US8622988B2
(en)
|
2008-08-31 |
2014-01-07 |
Abbott Diabetes Care Inc. |
Variable rate closed loop control and methods
|
US20100057040A1
(en)
|
2008-08-31 |
2010-03-04 |
Abbott Diabetes Care, Inc. |
Robust Closed Loop Control And Methods
|
US8734422B2
(en)
|
2008-08-31 |
2014-05-27 |
Abbott Diabetes Care Inc. |
Closed loop control with improved alarm functions
|
US9943644B2
(en)
|
2008-08-31 |
2018-04-17 |
Abbott Diabetes Care Inc. |
Closed loop control with reference measurement and methods thereof
|
US8986208B2
(en)
|
2008-09-30 |
2015-03-24 |
Abbott Diabetes Care Inc. |
Analyte sensor sensitivity attenuation mitigation
|
EP3025727A1
(de)
|
2008-10-02 |
2016-06-01 |
The J. David Gladstone Institutes |
Verfahren zur behandlung von lebererkrankungen
|
US20100104654A1
(en)
|
2008-10-27 |
2010-04-29 |
Allergan, Inc. |
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
US9326707B2
(en)
|
2008-11-10 |
2016-05-03 |
Abbott Diabetes Care Inc. |
Alarm characterization for analyte monitoring devices and systems
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
DE102008059206A1
(de)
|
2008-11-27 |
2010-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
|
SG173167A1
(en)
|
2009-01-29 |
2011-08-29 |
Forsight Labs Llc |
Posterior segment drug delivery
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
US8103456B2
(en)
|
2009-01-29 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and device for early signal attenuation detection using blood glucose measurements
|
US9402544B2
(en)
|
2009-02-03 |
2016-08-02 |
Abbott Diabetes Care Inc. |
Analyte sensor and apparatus for insertion of the sensor
|
US20100204325A1
(en)
|
2009-02-11 |
2010-08-12 |
Allergan, Inc. |
Valproic acid drug delivery systems and intraocular therapeutic uses thereof
|
JP2012520884A
(ja)
|
2009-03-18 |
2012-09-10 |
ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー |
フラビウイルス科ウイルス感染症を治療する方法および組成物
|
US8497777B2
(en)
|
2009-04-15 |
2013-07-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring system having an alert
|
EP2419015A4
(de)
|
2009-04-16 |
2014-08-20 |
Abbott Diabetes Care Inc |
Kalibrierung eines analytsensors
|
WO2010124296A2
(en)
|
2009-04-24 |
2010-10-28 |
Tissuetech, Inc. |
Compositions containing hc•ha complex and methods of use thereof
|
WO2010127050A1
(en)
|
2009-04-28 |
2010-11-04 |
Abbott Diabetes Care Inc. |
Error detection in critical repeating data in a wireless sensor system
|
US8368556B2
(en)
|
2009-04-29 |
2013-02-05 |
Abbott Diabetes Care Inc. |
Method and system for providing data communication in continuous glucose monitoring and management system
|
WO2010127051A1
(en)
|
2009-04-29 |
2010-11-04 |
Abbott Diabetes Care Inc. |
Method and system for providing real time analyte sensor calibration with retrospective backfill
|
US20100278897A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Allergan, Inc. |
Intraocular bioactive agent delivery system with molecular partitioning system
|
US8372036B2
(en)
*
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
US9184490B2
(en)
|
2009-05-29 |
2015-11-10 |
Abbott Diabetes Care Inc. |
Medical device antenna systems having external antenna configurations
|
KR20140069381A
(ko)
|
2009-06-02 |
2014-06-10 |
다우 글로벌 테크놀로지스 엘엘씨 |
서방출 투여형
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
WO2010148409A1
(en)
*
|
2009-06-19 |
2010-12-23 |
Knopp Neurosciences, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
US8613892B2
(en)
|
2009-06-30 |
2013-12-24 |
Abbott Diabetes Care Inc. |
Analyte meter with a moveable head and methods of using the same
|
US9795326B2
(en)
|
2009-07-23 |
2017-10-24 |
Abbott Diabetes Care Inc. |
Continuous analyte measurement systems and systems and methods for implanting them
|
WO2011021594A1
(ja)
|
2009-08-18 |
2011-02-24 |
国立大学法人東北大学 |
持続性ドラッグデリバリーシステム
|
WO2011026147A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Diabetes Care Inc. |
Analyte signal processing device and methods
|
EP4070729A1
(de)
|
2009-08-31 |
2022-10-12 |
Abbott Diabetes Care, Inc. |
Anzeigeeinheiten für ein medizinisches gerät
|
EP2473099A4
(de)
|
2009-08-31 |
2015-01-14 |
Abbott Diabetes Care Inc |
Analytüberwachungssystem und -verfahren zur leistungs- und rauschverwaltung
|
EP2473963A4
(de)
|
2009-08-31 |
2014-01-08 |
Abbott Diabetes Care Inc |
Medizinische geräte und verfahren
|
WO2011032011A1
(en)
|
2009-09-10 |
2011-03-17 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
DE102009042855A1
(de)
*
|
2009-09-24 |
2011-03-31 |
Pfenning Elektroanlagen Gmbh |
Portalhubwagen zum Einsatz in Containerterminals und für allgemeine Transportaufgaben
|
US9320461B2
(en)
|
2009-09-29 |
2016-04-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing notification function in analyte monitoring systems
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
US8185181B2
(en)
|
2009-10-30 |
2012-05-22 |
Abbott Diabetes Care Inc. |
Method and apparatus for detecting false hypoglycemic conditions
|
NZ716349A
(en)
|
2009-11-09 |
2017-07-28 |
Allergan Inc |
Compositions and methods for stimulating hair growth
|
EP2512389B1
(de)
|
2009-12-16 |
2015-09-02 |
Allergan, Inc. |
Intrakamerale vorrichtungen für verzögerte freisetzung
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
US20110172637A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Drug delivery device including tissue support structure
|
US20110172639A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Device and method for delivery of microneedle to desired depth within the skin
|
US20110172609A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
US20110172645A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Wearable drug delivery device including integrated pumping and activation elements
|
USD924406S1
(en)
|
2010-02-01 |
2021-07-06 |
Abbott Diabetes Care Inc. |
Analyte sensor inserter
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
EP2549918B2
(de)
|
2010-03-24 |
2023-01-25 |
Abbott Diabetes Care, Inc. |
Vorrichtungen zum einsetzen von medizingeräten sowie verfahren zum einsetzen und anwenden von medizingeräten
|
TR201802207T4
(tr)
|
2010-03-29 |
2018-03-21 |
Astellas Pharma Inc |
Kontrollü Salımlı Farmasötik Bileşim.
|
EP2558866B1
(de)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potenzierung einer antikrebs-wirkung durch eine kombinationstherapie mit ber-pfad-hemmern
|
US8754219B2
(en)
|
2010-04-27 |
2014-06-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
ES2591004T3
(es)
|
2010-04-27 |
2016-11-24 |
Calcimedica, Inc. |
Compuestos moduladores del calcio intracelular
|
MY191929A
(en)
|
2010-06-03 |
2022-07-18 |
Pharmacyclics Llc |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
US8635046B2
(en)
|
2010-06-23 |
2014-01-21 |
Abbott Diabetes Care Inc. |
Method and system for evaluating analyte sensor response characteristics
|
US11064921B2
(en)
|
2010-06-29 |
2021-07-20 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
US10092229B2
(en)
|
2010-06-29 |
2018-10-09 |
Abbott Diabetes Care Inc. |
Calibration of analyte measurement system
|
HUE054113T2
(hu)
|
2010-08-05 |
2021-08-30 |
Forsight Vision4 Inc |
Injekciós készülék gyógyszerbejuttatáshoz
|
CA2807537C
(en)
|
2010-08-05 |
2018-09-18 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
EP2600812B1
(de)
|
2010-08-05 |
2021-09-22 |
ForSight Vision4, Inc. |
Vorrichtung zur behandlung eines auges
|
CN114591311A
(zh)
|
2010-08-27 |
2022-06-07 |
钙医学公司 |
调节细胞内钙的化合物
|
WO2012048168A2
(en)
|
2010-10-07 |
2012-04-12 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods
|
WO2012061556A1
(en)
|
2010-11-03 |
2012-05-10 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
CA2818612C
(en)
|
2010-11-19 |
2020-12-29 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US8518440B2
(en)
|
2010-12-21 |
2013-08-27 |
Confluent Surgical, Inc. |
Biodegradable osmotic pump implant for drug delivery
|
HUE026715T2
(en)
|
2011-01-20 |
2016-07-28 |
Bionevia Pharmaceuticals Inc |
Modified release pharmaceutical composition comprising Epalrestat or a derivative thereof and methods of their use
|
US8801768B2
(en)
*
|
2011-01-21 |
2014-08-12 |
Endologix, Inc. |
Graft systems having semi-permeable filling structures and methods for their use
|
CA2827196A1
(en)
|
2011-02-28 |
2012-11-15 |
Jai Karan |
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
|
US10136845B2
(en)
|
2011-02-28 |
2018-11-27 |
Abbott Diabetes Care Inc. |
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
|
DE102011007272A1
(de)
|
2011-04-13 |
2012-10-18 |
Bayer Pharma Aktiengesellschaft |
Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
|
DK3575796T3
(da)
|
2011-04-15 |
2021-01-18 |
Dexcom Inc |
Avanceret analytsensorkalibrering og fejldetektion
|
WO2012149486A1
(en)
|
2011-04-28 |
2012-11-01 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
EP2717888B1
(de)
|
2011-06-10 |
2020-09-09 |
Tissuetech, Inc. |
Verfahren zur verarbeitung fötaler gewebesubstrate
|
BR112013032199A2
(pt)
|
2011-06-14 |
2017-12-12 |
Bikam Pharmaceuticals Inc |
ligantes de ligação à opsina, composições e métodos de utilização
|
WO2012175698A1
(en)
|
2011-06-23 |
2012-12-27 |
Université Libre de Bruxelles |
Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease
|
EP4249059A3
(de)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
|
WO2013006643A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
EP2739252A4
(de)
|
2011-08-05 |
2015-08-12 |
Forsight Vision4 Inc |
Abgabe kleiner moleküle über eine implantierbare therapeutische vorrichtung
|
EP2751291B1
(de)
|
2011-09-01 |
2018-08-15 |
University of Southern California |
Verfahren zur herstellung von peptidomimetika mit hohem durchsatz, oral bioverfügbaren wirkstoffen und zusammensetzungen damit
|
KR101892788B1
(ko)
|
2011-09-13 |
2018-08-28 |
파마싸이클릭스 엘엘씨 |
벤다무스틴과 조합된 히스톤 디아세틸라제 억제제의 제제 및 그의 용도
|
PL2755600T3
(pl)
|
2011-09-16 |
2021-09-20 |
Forsight Vision4, Inc. |
Urządzenie do wymiany płynów
|
CA2856703A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
US9069536B2
(en)
|
2011-10-31 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Electronic devices having integrated reset systems and methods thereof
|
WO2013066849A1
(en)
|
2011-10-31 |
2013-05-10 |
Abbott Diabetes Care Inc. |
Model based variable risk false glucose threshold alarm prevention mechanism
|
AU2012335830B2
(en)
|
2011-11-07 |
2017-05-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
EP2782584B1
(de)
|
2011-11-23 |
2021-06-09 |
TherapeuticsMD, Inc. |
Natürliche kombinierte hormonersatzformulierungen und -therapien
|
US9317656B2
(en)
|
2011-11-23 |
2016-04-19 |
Abbott Diabetes Care Inc. |
Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
|
US8710993B2
(en)
|
2011-11-23 |
2014-04-29 |
Abbott Diabetes Care Inc. |
Mitigating single point failure of devices in an analyte monitoring system and methods thereof
|
EP2785346A4
(de)
|
2011-11-30 |
2015-04-29 |
Bikam Pharmaceuticals Inc |
Opsinbindende liganden, zusammensetzungen damit und anwendungsverfahren dafür
|
BR112014013106A2
(pt)
|
2011-12-01 |
2017-06-13 |
Bikam Pharmaceuticals Inc |
ligantes de ligação à opsina, composições e métodos de uso
|
CN104066432B
(zh)
|
2011-12-06 |
2017-06-13 |
小利兰·斯坦福大学董事会 |
用于治疗病毒性疾病的方法和组合物
|
EP4056105B1
(de)
|
2011-12-11 |
2023-10-11 |
Abbott Diabetes Care, Inc. |
Analytsensorvorrichtungen
|
US9512096B2
(en)
|
2011-12-22 |
2016-12-06 |
Knopp Biosciences, LLP |
Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
PT2800565T
(pt)
|
2012-01-06 |
2020-04-29 |
Scripps Research Inst |
Compostos de carbamato e processos para a sua preparação e utilização
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
EP3311847A1
(de)
|
2012-02-16 |
2018-04-25 |
Atyr Pharma, Inc. |
Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
|
CA2906274A1
(en)
|
2012-03-14 |
2013-09-19 |
Medipacs, Inc. |
Smart polymer materials with excess reactive molecules
|
EA201492026A1
(ru)
|
2012-05-07 |
2015-09-30 |
Байер Фарма Акциенгезельшафт |
Способ изготовления фармацевтической лекарственной формы, содержащей нифедипин и кандесартан цилексетил
|
UA126959C2
(uk)
|
2012-06-04 |
2023-03-01 |
Фармасайклікс Ллс |
Фармацевтична композиція, що містить інгібітор тирозинкінази брутона
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
UY34856A
(es)
|
2012-07-03 |
2013-12-31 |
Bayer Pharma AG |
Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
|
US10040821B2
(en)
|
2012-07-11 |
2018-08-07 |
Tissuetech, Inc. |
Compositions containing HC-HA/PTX3 complexes and methods of use thereof
|
EP2890297B1
(de)
|
2012-08-30 |
2018-04-11 |
Abbott Diabetes Care, Inc. |
Ausfallerkennung bei kontinuierlichen analytüberwachungsdaten bei datenabweichungen
|
US9968306B2
(en)
|
2012-09-17 |
2018-05-15 |
Abbott Diabetes Care Inc. |
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
|
WO2014052136A1
(en)
|
2012-09-26 |
2014-04-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
|
CA2885828C
(en)
|
2012-09-28 |
2021-04-27 |
University Of Washington Through Its Center For Commercialization |
Ureido-thiophenyl derivatives, compositions thereof and methods for preventing, treating and/or protecting against sensory hair cell death
|
US9717741B2
(en)
|
2012-10-11 |
2017-08-01 |
Anaplasi Pharmaceuticals Llc |
Method and compositions for treating psoriasis
|
JP6059352B2
(ja)
|
2012-10-11 |
2017-01-11 |
アナプラシ ファーマシューティカルズ エルエルシー |
乾癬を治療するための方法及び組成物
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
GB2510826B
(en)
|
2013-02-13 |
2015-09-02 |
Animax Ltd |
Improvements in or relating to release of a beneficial substance from a bolus
|
AU2014216112B2
(en)
|
2013-02-15 |
2019-02-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
US9968603B2
(en)
|
2013-03-14 |
2018-05-15 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US9572885B2
(en)
|
2013-03-15 |
2017-02-21 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
US9474475B1
(en)
|
2013-03-15 |
2016-10-25 |
Abbott Diabetes Care Inc. |
Multi-rate analyte sensor data collection with sample rate configurable signal processing
|
US10433773B1
(en)
|
2013-03-15 |
2019-10-08 |
Abbott Diabetes Care Inc. |
Noise rejection methods and apparatus for sparsely sampled analyte sensor data
|
US10076285B2
(en)
|
2013-03-15 |
2018-09-18 |
Abbott Diabetes Care Inc. |
Sensor fault detection using analyte sensor data pattern comparison
|
JP6385423B2
(ja)
|
2013-03-28 |
2018-09-05 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
治療物質送達用の眼移植片
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
US10828284B2
(en)
|
2013-07-12 |
2020-11-10 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
|
WO2015023786A1
(en)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
|
AU2014306597B2
(en)
|
2013-08-13 |
2018-05-17 |
Knopp Biosciences Llc |
Compositions and methods for treating chronic urticaria
|
WO2015054283A1
(en)
|
2013-10-08 |
2015-04-16 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
MX2016007111A
(es)
|
2013-12-05 |
2016-08-11 |
Pharmacyclics Llc |
Inhibidores de tirosina quinasa de bruton.
|
CN105899132B
(zh)
|
2013-12-31 |
2020-02-18 |
雅培糖尿病护理公司 |
自供电分析物传感器以及使用其的装置
|
EP3865063A1
(de)
|
2014-03-30 |
2021-08-18 |
Abbott Diabetes Care, Inc. |
Verfahren und vorrichtung zur bestimmung des starts einer mahlzeit und von spitzenwertereignissen in analytüberwachungssystemen
|
WO2015164213A1
(en)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
JP2017516768A
(ja)
|
2014-05-22 |
2017-06-22 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
天然の併用ホルモン補充療法剤及び療法
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
JP6581194B2
(ja)
|
2014-07-15 |
2019-09-25 |
フォーサイト・ビジョン フォー・インコーポレーテッドForsight Vision4, Inc. |
眼用インプラント送達装置および方法
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
WO2016016770A1
(en)
|
2014-07-26 |
2016-02-04 |
Wockhardt Limited |
A novel modified release pharmaceutical composition of sitagliptin or pharmaceutically acceptable salt thereof
|
CN107106551A
(zh)
|
2014-08-08 |
2017-08-29 |
弗赛特影像4股份有限公司 |
受体酪氨酸激酶抑制剂的稳定且可溶的制剂和其制备方法
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
SG11201703726XA
(en)
|
2014-11-10 |
2017-06-29 |
Forsight Vision4 Inc |
Expandable drug delivery devices and method of use
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10213586B2
(en)
|
2015-01-28 |
2019-02-26 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
US9493482B2
(en)
|
2015-02-06 |
2016-11-15 |
University Of Washington |
Compounds and methods for preventing or treating sensory hair cell death
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
EP3258916A1
(de)
|
2015-02-20 |
2017-12-27 |
Osmotica Kereskedelmi ES Szolgaltato KFT |
Oralen darreichungsform mit kontrollierter freisetzung aus gaba-rezeptor-agonisten mit verbesserter pharmakokinetik
|
TW201642914A
(zh)
|
2015-02-23 |
2016-12-16 |
組織科技股份有限公司 |
用於治療眼部疾病及失調的裝置及方法
|
JP2018510138A
(ja)
|
2015-02-27 |
2018-04-12 |
カーテナ ファーマシューティカルズ,インク. |
Olig2活性の阻害
|
AU2016226279B2
(en)
|
2015-03-03 |
2021-11-11 |
Pharmacyclics Llc |
Pharmaceutical formulations of Bruton's tyrosine kinase inhibtor
|
AU2016228779A1
(en)
|
2015-03-12 |
2017-09-07 |
Chrono Therapeutics Inc. |
Craving input and support system
|
MA41827A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton
|
MA41828A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton
|
US10575976B2
(en)
|
2015-04-30 |
2020-03-03 |
Dynamic Mouth Devices, L.L.C. |
Method and apparatus for weight management utilizing an intra-oral device
|
EP3294731A4
(de)
|
2015-05-11 |
2018-10-24 |
Abide Therapeutics, Inc. |
Verfahren zur behandlung von entzündungen oder neuropathischem schmerz
|
CA2984939A1
(en)
|
2015-05-14 |
2016-11-17 |
Abbott Diabetes Care Inc. |
Compact medical device inserters and related systems and methods
|
US10213139B2
(en)
|
2015-05-14 |
2019-02-26 |
Abbott Diabetes Care Inc. |
Systems, devices, and methods for assembling an applicator and sensor control device
|
WO2016187555A1
(en)
|
2015-05-20 |
2016-11-24 |
Tissuetech, Inc. |
Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
|
JP6986007B2
(ja)
|
2015-07-10 |
2021-12-22 |
アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. |
生理学的パラメータに対する動的グルコースプロファイル応答のシステム、デバイス及び方法
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017023863A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
MX2018002554A
(es)
|
2015-08-31 |
2018-08-14 |
Pharmacyclics Llc |
Combinaciones de inhibidores de btk para tratar mieloma multiple.
|
EP3365027B1
(de)
|
2015-10-14 |
2022-03-30 |
Research Institute at Nationwide Children's Hospital |
Hu-spezifische antikörper und deren verwendeng zur hemmung von biofilm
|
CN113069681B
(zh)
|
2015-11-20 |
2022-12-23 |
弗赛特影像4股份有限公司 |
制造用于缓释药物递送的治疗装置的方法
|
DK3827838T3
(da)
|
2015-12-16 |
2023-06-26 |
Walter & Eliza Hall Inst Medical Res |
Hæmning af cytokin-induceret sh2-protein i nk-celler
|
AU2017208473B2
(en)
|
2016-01-19 |
2022-04-21 |
Janssen Pharmaceutica Nv |
Formulations/compositions comprising a BTK inhibitor
|
MX2018008771A
(es)
|
2016-01-19 |
2018-11-09 |
Janssen Pharmaceutica Nv |
Formulaciones/composiciones que comprenden un inhibidor de btk.
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
WO2017147146A1
(en)
|
2016-02-23 |
2017-08-31 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic trpv1 agonists
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
JP7049683B2
(ja)
|
2016-04-04 |
2022-04-07 |
シノピア バイオサイエンシーズ,インク. |
トラピジルを使用する錐体外路症候群の処置
|
CA3019822A1
(en)
|
2016-04-05 |
2017-10-12 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
JP2019516773A
(ja)
|
2016-05-25 |
2019-06-20 |
コンセントリック アナルジジックス,インク. |
改善された局所麻酔のための局所麻酔薬及び血管収縮薬と組み合わせたフェノールtrpv1アゴニストのプロドラッグ
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
JP2019524747A
(ja)
|
2016-07-18 |
2019-09-05 |
アースローシ セラピューティクス,インク. |
痛風または高尿酸血症に関連する症状を処置または予防するための化合物、組成物、および方法
|
KR102605329B1
(ko)
|
2016-08-26 |
2023-11-22 |
커타나 파마슈티칼스, 인크. |
Olig2 활성의 억제
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
CA3043609A1
(en)
|
2016-11-16 |
2018-05-24 |
Abide Therapeutics, Inc. |
Pharmaceutical formulations
|
HRP20231697T1
(hr)
|
2016-11-16 |
2024-03-15 |
H. Lundbeck A/S |
Kristalni oblik magl inhibitora
|
EP3565589A1
(de)
|
2017-01-04 |
2019-11-13 |
Research Institute at Nationwide Children's Hospital |
Dnabii-impfstoffe und antikörper mit erhöhter aktivität
|
JP2020506221A
(ja)
|
2017-01-04 |
2020-02-27 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
バイオフィルム関連障害の処置のための抗体断片
|
JP2020503950A
(ja)
|
2017-01-06 |
2020-02-06 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
経皮薬剤送達の装置及び方法
|
CN110461217B
(zh)
|
2017-01-23 |
2022-09-16 |
雅培糖尿病护理公司 |
用于分析物传感器插入的系统、装置和方法
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
EP3600014A4
(de)
|
2017-03-21 |
2020-10-21 |
Abbott Diabetes Care Inc. |
Verfahren, vorrichtungen und system zur bereitstellung der diagnose und therapie von diabetischen zuständen
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
JP7397487B2
(ja)
|
2017-09-01 |
2023-12-13 |
ユニヴァーシティ オブ ワシントン |
感覚有毛細胞死を予防または処置するための化合物の結晶形態
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US11331022B2
(en)
|
2017-10-24 |
2022-05-17 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
CN209606445U
(zh)
|
2017-10-24 |
2019-11-08 |
德克斯康公司 |
预连接分析物传感器
|
WO2019103906A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
RU2020129191A
(ru)
|
2018-02-16 |
2022-03-16 |
Эсперион Терапеутикс, Инк. |
Композиции с замедленным высвобождением бемпедоевой кислоты
|
WO2019165993A1
(zh)
|
2018-02-28 |
2019-09-06 |
上海汉都医药科技有限公司 |
一种药物组合物及其制备方法和应用
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
US11000471B2
(en)
|
2018-03-05 |
2021-05-11 |
Kashiv Specialty Pharmaceuticals, Llc |
Programmable pharmaceutical compositions for chrono drug release
|
WO2019223753A1
(zh)
|
2018-05-23 |
2019-11-28 |
上海汉都医药科技有限公司 |
活性药物成分的控释系统及其制备方法
|
US11911513B2
(en)
|
2018-05-23 |
2024-02-27 |
Shanghai Wd Pharmaceutical Co., Ltd |
Controlled-release system of active pharmaceutical ingredient and preparation method therefor
|
CA3101966A1
(en)
|
2018-05-29 |
2019-12-05 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
US10905667B2
(en)
|
2018-07-24 |
2021-02-02 |
Bayer Pharma Aktiengesellschaft |
Orally administrable modified-release pharmaceutical dosage form
|
KR20210035235A
(ko)
|
2018-07-24 |
2021-03-31 |
바이엘 악티엔게젤샤프트 |
경구 투여될 수 있고 변형된 방출을 갖는 제약학적 투여 형태
|
CN112469398A
(zh)
|
2018-07-24 |
2021-03-09 |
拜耳公司 |
可口服给药并具有缓释作用的药物剂型
|
US10717712B2
(en)
|
2018-07-27 |
2020-07-21 |
Concentric Analgesics, Inc. |
Pegylated prodrugs of phenolic TRPV1 agonists
|
EP3906026A4
(de)
|
2018-12-31 |
2022-10-19 |
Biomea Fusion, LLC |
Irreversible inhibitoren der menin-mll-interaktion
|
CA3133093A1
(en)
|
2019-03-15 |
2020-09-24 |
Unicycive Therapeutics, Inc. |
Nicorandil derivatives
|
USD1002852S1
(en)
|
2019-06-06 |
2023-10-24 |
Abbott Diabetes Care Inc. |
Analyte sensor device
|
EP3750528A1
(de)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Zusammensetzungen zur behandlung von dystrophien und myotonie
|
US20220275064A1
(en)
|
2019-07-08 |
2022-09-01 |
Research Institute At Nationwide Children's Hospital |
Antibody compositions for disrupting biofilms
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
IL297470A
(en)
|
2020-04-21 |
2022-12-01 |
H Lundbeck As |
Synthesis of a monoacylglycerol lipase inhibitor
|
KR20240025706A
(ko)
|
2020-06-10 |
2024-02-27 |
오스펙스 파마슈티칼스, 인코포레이티드 |
듀테트라베나진을 포함하는 삼투성 제형 및 이의 사용 방법
|
CA3202151A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
USD999913S1
(en)
|
2020-12-21 |
2023-09-26 |
Abbott Diabetes Care Inc |
Analyte sensor inserter
|
CA3204457A1
(en)
|
2021-01-06 |
2022-07-14 |
Ben SESSA |
Mdma in the treatment of alcohol use disorder
|
CA3218884A1
(en)
|
2021-05-11 |
2022-11-17 |
David Nutt |
Therapeutic aminoindane compounds and compositions
|
WO2022247952A1
(zh)
*
|
2021-05-28 |
2022-12-01 |
上海博志研新药物技术有限公司 |
硝苯地平美托洛尔缓释组合物、其制备方法及应用
|
AU2022283967A1
(en)
|
2021-06-03 |
2024-01-18 |
Arcadia Medicine, Inc. |
Enantiomeric entactogen compositions and methods of their use
|
TW202320796A
(zh)
|
2021-08-11 |
2023-06-01 |
美商拜歐米富士恩股份有限公司 |
用於糖尿病的menin-mll相互作用之共價抑制劑
|
CA3229150A1
(en)
|
2021-08-20 |
2023-02-23 |
Biomea Fusion, Inc. |
Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cance
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
WO2023039240A1
(en)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
TW202340177A
(zh)
|
2021-12-30 |
2023-10-16 |
美商拜歐米富士恩股份有限公司 |
作為 flt3抑制劑之吡嗪化合物
|
WO2023139163A1
(en)
|
2022-01-19 |
2023-07-27 |
Awakn Ls Europe Holdings Limited |
1,3-benzodioxole esters and their therapeutic use
|
CN115490316B
(zh)
*
|
2022-01-24 |
2023-09-12 |
成都理工大学 |
一种可再利用的地下水营养物质缓释胶囊体
|
WO2023156565A1
(en)
|
2022-02-16 |
2023-08-24 |
Awakn Ls Europe Holdings Limited |
Bridged ring compounds and their therapeutic use as cns agents
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
WO2023240186A1
(en)
|
2022-06-08 |
2023-12-14 |
Auspex Pharmaceuticals, Inc. |
Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
|
US20240010649A1
(en)
|
2022-07-06 |
2024-01-11 |
Oppilan Pharma Limited |
Crystalline forms of an s1p receptor modulator
|
US11931224B1
(en)
*
|
2022-12-19 |
2024-03-19 |
Robert Parker |
Tooth pod
|